Elevated troponin: A marker for noncardiac complications after resection of head and neck cancers
The Laryngoscope Oct 05, 2019
McHugh T, et al. - Experts aspired to explore whether troponin positivity (TP) in individuals who had head and neck cancer mucosal resections (HNS) anticipates noncardiac complications. From July 2014 to July 2016, all patients who had HNS at a tertiary-care cancer center were involved and had postoperative troponin measurements as part of an institutional cardiac protocol. For this investigation, 172 patients underwent HNS. During the postoperative period, 15% of those developed TP. No significant difference was found between TP and TN for gender, tumor-node-metastasis staging, Charlson comorbidity index, and smoking status. The finding suggested that TP is not a rare occurrence after HNS and is linked to statistically significant increases in wound complications, LOHS, and pneumonia. The overall significance of these findings remains unclear, however, and further research is warranted to determine whether outcomes can be improved by closely monitoring these TP patients.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries